EBS – emergent biosolutions, inc. (US:NASDAQ)
Stock Stats
News
Emergent Biosolutions (NYSE:EBS) had its "buy" rating reaffirmed by analysts at HC Wainwright. They now have a $15.00 price target on the stock.
Emergent BioSolutions Receives U.S. FDA Approval for Drug Product Manufacturing of raxibacumab at its Winnipeg, Canada Site
Emergent Biosolutions (NYSE:EBS) had its "hold (c-)" rating reaffirmed by analysts at Weiss Ratings.
Emergent Biosolutions (NYSE:EBS) was upgraded by analysts at Wall Street
Emergent Biosolutions (NYSE:EBS) had its "hold (c-)" rating reaffirmed by analysts at Weiss Ratings.
Form 144 Emergent BioSolutions Filed by: SULLIVAN LOUIS W
Form 4 Emergent BioSolutions For: Dec 14 Filed by: Lowry Simon C
Form 8-K Emergent BioSolutions For: Dec 12
Form 4 Emergent BioSolutions For: Dec 05 Filed by: Richard Ronald
Form 144 Emergent BioSolutions Filed by: Richard Ronald
Live Event: How Top Hedge Funds Use News To Make Money From The Stock Market & How Ordinary People Are Copying Their Strategies
If you could use the news to make money from the stock market, would you? Join us on our live online event where you’ll discover this simple scientific method that has allowed ordinary people get a huge return from the stock market without excessive risk.